Comment on: 'Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients' Radiother Oncol 70: 261-264, 2004 by Dr Rades et al

Radiother Oncol. 2004 Oct;73(1):109; author reply 109-10. doi: 10.1016/j.radonc.2004.07.027.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amifostine / adverse effects*
  • Head and Neck Neoplasms / radiotherapy*
  • Humans
  • Lung Neoplasms / radiotherapy
  • Radiation-Protective Agents / adverse effects*

Substances

  • Radiation-Protective Agents
  • Amifostine